Diagnostic Imaging Equipment
Companies manufacturing MRI, CT, ultrasound, X-ray, and point-of-care diagnostic imaging systems.
- 5
- Verticals
Overview
Diagnostic Imaging Equipment covers manufacturers of MRI, CT, ultrasound, X-ray, and point-of-care diagnostic systems, alongside in-vitro diagnostic substances. The imaging-systems market is a consolidated oligopoly (GE HealthCare, Siemens Healthineers, Philips), with AI-enabled imaging and point-of-care a key innovation vector.
Demand is driven by diagnostic volumes, replacement cycles, and the integration of AI into imaging workflows. It is a large, capital-equipment-and-consumables business with recurring service and contrast/reagent revenue. Growth has been supported by diagnostics expansion and imaging innovation.
Market snapshot
- Market size
- ~$32B
- Growth
- ~6.3%CAGR (2017–22, nominal)
- Companies
- ~314 firms
50% of firms have fewer than 20 employees: 157 micro-businesses, below most mandates.
- 20–99
- 6944%
- 100–499
- 4126%
- 500+
- 4730%
A consolidated oligopoly — GE HealthCare, Siemens Healthineers, Philips — of ~314 firms, the most asset-heavy device slice (payroll just 17% of revenue, ~$103M revenue per firm). AI-enabled imaging and point-of-care drove ~6%/yr growth. The figure combines in-vitro diagnostics and irradiation apparatus; broader imaging electronics span other codes, so it is an imperfect proxy.
NAICS 325413, 334517. U.S. Census Bureau — 2022 Statistics of U.S. Businesses; U.S. Census Bureau — 2022 Economic Census.
Business model & economics
Revenue model
Capital equipment plus recurring service and consumables
Key economics
- Revenue per firm
- $102,863,487
- Revenue per employee
- $576,976
- Employees per firm
- 167.6
- Recurring revenue
- Moderate–High
- EBITDA margin
- 15–25%
- Capex intensity
- High
service contracts and reagents
Characteristics
- Scale-driven — payroll is only 17% of revenue; the cost base is assets, not headcount
- Moderate strategic-buyer pool — 47 firms exceed 500 employees; a scaled asset has buyers, but not many
- Consolidated oligopoly in imaging systems.
- AI-enabled imaging and point-of-care innovation.
- Recurring service and contrast/reagent revenue.
NAICS 325413, 334517. U.S. Census Bureau — 2022 Statistics of U.S. Businesses; U.S. Census Bureau — 2022 Economic Census.
M&A deal context
Who’s acquiring
- Imaging & diagnostics strategics
- AI-imaging acquirers
- Diagnostics platforms
What’s driving deals
- AI-imaging and point-of-care acquisitions.
- Diagnostics expansion and replacement cycles.
- Recurring service and consumables economics.
Verticals in this segment
Find Diagnostic Imaging Equipment acquisition targets
Search Acquisera’s index for companies classified under Diagnostic Imaging Equipment (4.8.4) and build a targeted deal pipeline.
Search companies